Written by Global Viscosupplementation Market Forecast Report (2025–2033)
Title: Viscosupplementation Market to Hit US$ 10.16 Billion by 2033, Driven by Aging Population and Demand for Non-Invasive Joint Treatments
Introduction The global viscosupplementation market is set for robust growth, projected to rise from US$ 4.66 billion in 2024 to US$ 10.16 billion by 2033, expanding at a CAGR of 9.02% during the forecast period. This surge is fueled by the rising prevalence of osteoarthritis, growing elderly populations, and the increasing preference for non-surgical treatment methods.
Market Overview Viscosupplementation involves injecting hyaluronic acid into joints to improve lubrication and reduce pain, particularly for patients suffering from osteoarthritis. It is minimally invasive, making it a favorable alternative to surgery. While the knee remains the most commonly treated joint, viscosupplementation applications are expanding to other areas such as the hip, wrist, ankle, and shoulder.
Market Drivers
- Rising Osteoarthritis Incidence: Osteoarthritis affects over 300 million people globally. Aging demographics—especially in developed economies—are significantly driving demand for viscosupplementation.
- Preference for Minimally Invasive Therapies: Patients are seeking alternatives to joint replacement surgeries due to associated risks and lengthy recovery times. Viscosupplementation offers a non-invasive solution with fewer complications.
- Advancements in Hyaluronic Acid (HA) Formulations: Improved HA formulations provide longer-lasting relief and require fewer injections, increasing patient compliance and satisfaction.
Market Challenges
- High Cost of Treatment: A single viscosupplementation injection can be expensive and is not always fully covered by insurance, especially in developing regions.
- Lack of Awareness: Many patients and healthcare providers remain unaware of viscosupplementation as an effective treatment, which restricts market penetration.
Segmental Insights
By Injection Type
- Single Injection: The fastest-growing segment due to convenience and patient preference. New product launches and outpatient treatment trends are propelling its adoption.
- Three and Five Injections: Traditionally used methods still widely available but gradually losing favor to single-dose options.
By Application
- Knee Osteoarthritis: Dominates the market with the highest share. This is primarily due to the increasing elderly population and high incidence of knee degeneration.
- Hip, Wrist, Ankle, and Other Joints: Emerging areas showing strong potential, driven by advancements in targeted HA treatments.
By End User
- Hospitals: Provide comprehensive treatment but face competition from more cost-efficient outpatient centers.
- Orthopedic Clinics & Ambulatory Surgical Centers: Witnessing high growth due to specialized services, reduced waiting times, and patient-centric care models.
Regional Analysis
United States: The largest market globally. Rising osteoarthritis prevalence, high healthcare spending, and innovation drive growth. For instance, Anika Therapeutics achieved positive results in Phase III studies for its Cingal product.
France: Significant growth is driven by an aging population and increasing awareness of non-invasive treatments. The French healthcare system’s accessibility encourages broader adoption.
China: Rapid expansion due to an aging population and increasing osteoarthritis cases. Government healthcare reforms and growing middle-class access to treatments contribute to rising demand.
Saudi Arabia: Witnessing growth with the expansion of high-end healthcare facilities and growing interest in surgical alternatives for joint care.
Competitive Landscape Leading players are focusing on product innovation, strategic partnerships, and expanding their regional presence. Key players include:
- Anika Therapeutics Inc.
- Zimmer Biomet
- Smith & Nephew PLC
- F. Hoffmann-La Roche Ltd
- Sanofi
- Chugai Pharmaceutical Co.
- Lifecore Biomedical
- LG Life Sciences Ltd
In December 2023, Bioventus Inc. signed a nationwide agreement with Aetna™ Medicare Advantage plans, further strengthening its market reach.
Demographic Trends According to the Population Reference Bureau, the number of people aged 65 and above in the U.S. is expected to increase from 58 million in 2022 to 82 million in 2050. This demographic shift underscores the growing demand for joint care solutions like viscosupplementation.
New Publish Blogs :
Top Transdermal Skin Patches Companies | Market Leaders 2025
Top Tilapia Companies Leading the Global Aquaculture Industry
Top Ice Cream Companies in the Global Market – 2025 Insights
Market Segmentation
By Product (Injection Type)
- Single Injection
- Three Injections
- Five Injections
By Application
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand/Wrist Osteoarthritis
- Ankle/Foot Osteoarthritis
- Others
By End User
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Conclusion The global viscosupplementation market is undergoing transformative growth, propelled by aging demographics, increasing awareness, and ongoing product innovations. As patients and healthcare providers seek alternatives to surgery for osteoarthritis management, viscosupplementation stands out as a cost-effective, minimally invasive, and highly effective treatment option.
About Renub Research
Renub Research is a leading market research and consulting company offering management consulting and in-depth industry analysis across various sectors. With a global perspective and a local understanding, Renub Research delivers insights that matter.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: mailto:[email protected]
Written by 
Written by